ConductScience.org, home

Paper23907438

Design and synthesis of a reagent for solid-phase incorporation of the phosphothreonine mimetic (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) into peptides in a bio-reversible phosphonyl-bis-pivaloyloxymethyl (POM) prodrug form.

Qian WJ and 1 other. Amino Acids, 2013. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Design and synthesis of a reagent for solid-phase incorporation of the phosphothreonine mimetic (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) into peptides in a bio-reversible phosphonyl-bis-pivaloyloxymethyl (POM) prodrug form. Papers, record 23907438. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23907438

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Design and synthesis of a reagent for solid-phase incorporation of the phosphothreonine mimetic (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) into peptides in a bio-reversible phosphonyl-bis-pivaloyloxymethyl (POM) prodrug form.
PubMed
Journal
Amino Acids
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, N.I.H., Intramural
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.19
iCite
Revised in PubMed
2025-05-29
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qian WJWen-Jian
2Burke TR JrTerrence R

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminobutyratesMajor topic
PeptidesMajor topic
PhosphothreonineMajor topic
ProdrugsMajor topic
Molecular Structure
Solid-Phase Synthesis Techniques

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
Y99 CA999999NCI NIH HHSUnited StatesY99CA999999PubMedNIH RePORTER
Z99 CA999999Intramural NIH HHSUnited StatesZ99CA999999PubMedNIH RePORTER
ZIA BC006198Intramural NIH HHSUnited StatesZIABC006198PubMed and NIHNIH RePORTER

Download CSV of grants

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122726690Synthesis of a phosphoserine mimetic prodrug with potent 14-3-3 protein inhibitory activity.Chem Biol2012https://conductscience.org/library/papers/22726690PubMed
219594124Synthesis of phosphatase-stable, cell-permeable peptidomimetic prodrugs that target the SH2 domain of Stat3.Org Lett2009https://conductscience.org/library/papers/19594124PubMed
317249650Synthesis and cell-based activity of a potent and selective protein tyrosine phosphatase 1B inhibitor prodrug.J Med Chem2007https://conductscience.org/library/papers/17249650PubMed
418359294Polo-box domains confer target specificity to the Polo-like kinase family.Biochim Biophys Acta2008https://conductscience.org/library/papers/18359294PubMed
521486047Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3.J Med Chem2011https://conductscience.org/library/papers/21486047PubMed
611667395
Ready Access to Fluorinated Phosphonate Mimics of Secondary Phosphates. Synthesis of the (alpha,alpha-Difluoroalkyl)phosphonate Analogues of L-Phosphoserine, L-Phosphoallothreonine, and L-Phosphothreonine.
J Org Chem1996https://conductscience.org/library/papers/11667395PubMed
711994738Phosphotyrosine-binding domains in signal transduction.Nat Rev Mol Cell Biol2002https://conductscience.org/library/papers/11994738PubMed
821284386Synthesis and biological evaluation of orally active prodrugs of indomethacin.J Med Chem2011https://conductscience.org/library/papers/21284386PubMed
97822106Efficient Fmoc/solid-phase synthesis of Abu(P)-containing peptides using Fmoc-Abu(PO3Me2)-OH.Int J Pept Protein Res1994https://conductscience.org/library/papers/7822106PubMed
1021765407Serendipitous alkylation of a Plk1 ligand uncovers a new binding channel.Nat Chem Biol2011https://conductscience.org/library/papers/21765407PubMed
1122292814Identification of high affinity polo-like kinase 1 (Plk1) polo-box domain binding peptides using oxime-based diversification.ACS Chem Biol2012https://conductscience.org/library/papers/22292814PubMed
1218237108Prodrugs of phosphates and phosphonates.J Med Chem2008https://conductscience.org/library/papers/18237108PubMed
1310956468Stereoselective synthesis of CF(2)-substituted phosphothreonine mimetics and their incorporation into peptides using newly developed deprotection procedures.J Org Chem2000https://conductscience.org/library/papers/10956468PubMed
1412809529Phosphotyrosyl mimetics in the development of signal transduction inhibitors.Acc Chem Res2003https://conductscience.org/library/papers/12809529PubMed
1512614874Prodrugs of biologically active phosphate esters.Bioorg Med Chem2003https://conductscience.org/library/papers/12614874PubMed
1622161995Current chemical biology tools for studying protein phosphorylation and dephosphorylation.Chemistry2012https://conductscience.org/library/papers/22161995PubMed
1722570300Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1.Chembiochem2012https://conductscience.org/library/papers/22570300PubMed
1824954959
Preparation of orthogonally protected (2S, 3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) as a phosphatase-stable phosphothreonine mimetic and its use in the synthesis of Polo-box domain-binding peptides.
Tetrahedron2009https://conductscience.org/library/papers/24954959PubMed
1919778720The alpha,alpha-difluorinated phosphonate L-pSer-analogue: an accessible chemical tool for studying kinase-dependent signal transduction.Chem Biol2009https://conductscience.org/library/papers/19778720PubMed
2017935986A phosphorylated prodrug for the inhibition of Pin1.Bioorg Med Chem Lett2007https://conductscience.org/library/papers/17935986PubMed

See all 22 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
35518575Phosphonopeptides containing free phosphonic groups: recent advances.RSC Adv2020https://conductscience.org/library/papers/35518575PubMed
30174151Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors.Bioorg Med Chem Lett2018https://conductscience.org/library/papers/30174151PubMed
25391982Prodrugs of phosphonates and phosphates: crossing the membrane barrier.Top Curr Chem2015https://conductscience.org/library/papers/25391982PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23907438

GET https://conductscience.org/api/papers/v1/23907438/references?page=2